Figure 3. Yearly Publications of Trials Supporting Approval of New Drugs: Publication of Pivotal Trials (n = 257/340).
Of the pivotal trials that were published, 95% were published within 3 y of FDA approval. Trials could be published prior to or following submission of data to the FDA.